These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. 4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation. Medapi B, Suryadevara P, Renuka J, Sridevi JP, Yogeeswari P, Sriram D. Eur J Med Chem; 2015 Oct 20; 103():1-16. PubMed ID: 26318054 [Abstract] [Full Text] [Related]
7. Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors. Medapi B, Meda N, Kulkarni P, Yogeeswari P, Sriram D. Bioorg Med Chem; 2016 Feb 15; 24(4):877-85. PubMed ID: 26787274 [Abstract] [Full Text] [Related]
8. Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: hit to lead optimization of a novel class of thiazole inhibitors. Jeankumar VU, Kotagiri S, Janupally R, Suryadevara P, Sridevi JP, Medishetti R, Kulkarni P, Yogeeswari P, Sriram D. Bioorg Med Chem; 2015 Feb 01; 23(3):588-601. PubMed ID: 25541204 [Abstract] [Full Text] [Related]
10. Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy. Kale RR, Kale MG, Waterson D, Raichurkar A, Hameed SP, Manjunatha MR, Kishore Reddy BK, Malolanarasimhan K, Shinde V, Koushik K, Jena LK, Menasinakai S, Humnabadkar V, Madhavapeddi P, Basavarajappa H, Sharma S, Nandishaiah R, Mahesh Kumar KN, Ganguly S, Ahuja V, Gaonkar S, Naveen Kumar CN, Ogg D, Boriack-Sjodin PA, Sambandamurthy VK, de Sousa SM, Ghorpade SR. Bioorg Med Chem Lett; 2014 Feb 01; 24(3):870-9. PubMed ID: 24405701 [Abstract] [Full Text] [Related]
11. Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase. Carta A, Bua A, Corona P, Piras S, Briguglio I, Molicotti P, Zanetti S, Laurini E, Aulic S, Fermeglia M, Pricl S. Eur J Med Chem; 2019 Jan 01; 161():399-415. PubMed ID: 30384044 [Abstract] [Full Text] [Related]
12. Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B. Kale MG, Raichurkar A, P SH, Waterson D, McKinney D, Manjunatha MR, Kranthi U, Koushik K, Jena Lk, Shinde V, Rudrapatna S, Barde S, Humnabadkar V, Madhavapeddi P, Basavarajappa H, Ghosh A, Ramya VK, Guptha S, Sharma S, Vachaspati P, Kumar KN, Giridhar J, Reddy J, Panduga V, Ganguly S, Ahuja V, Gaonkar S, Kumar CN, Ogg D, Tucker JA, Boriack-Sjodin PA, de Sousa SM, Sambandamurthy VK, Ghorpade SR. J Med Chem; 2013 Nov 14; 56(21):8834-48. PubMed ID: 24088190 [Abstract] [Full Text] [Related]